LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 5 Oct 2026
Medicines recall

MOVICOL Plain 13.7g powder for oral solution

Issued on 5 Oct 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Affected batches: 487069 (28/02/2029), 474919 (31/08/2028)
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 3 recall · DMRC - 40129134 · PL: 20142/0004 · licence holder: Norgine Limited · active ingredient: macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride · licence PL: 20142/0004

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 3 recall · DMRC - 40129134

ProductLicenceActive ingredientGTIN
MOVICOL Plain 13.7g powder for oral solutionPL: 20142/0004macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride05012748615328

Batches (expiry): 487069 (28/02/2029), 474919 (31/08/2028)

Background: Norgine Limited is recalling the above batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients. Advice for Healthcare Professionals: Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.